Tuberculosis Exposure in Children: Clinical Characteristics, and Short-term Outcomes
PDF
Cite
Share
Request
Original Article
E-PUB
22 September 2026

Tuberculosis Exposure in Children: Clinical Characteristics, and Short-term Outcomes

J Curr Pediatr. Published online 22 September 2026.
No information available.
No information available
Received Date: 14.05.2026
Accepted Date: 28.08.2026
E-Pub Date: 22.09.2026
PDF
Cite
Share
Request

Abstract

Introduction

This study aimed to evaluate the clinical, radiological, and laboratory findings of children with a history of contact with bacteriologically confirmed contagious adult pulmonary tuberculosis (TB) cases; to determine the risk factors for tuberculosis infection (TBI) and active disease development; and to assess the effects of administered prophylactic treatment regimens on short-term prognosis.

Materials and Methods

This retrospective study included 106 children aged 0–18 years who had close contact with bacteriologically confirmed adult pulmonary TB cases between January 1, 2016 and August 2017. Clinical characteristics, contact history, radiological and microbiological findings, and treatment regimens of the cases were evaluated.

Results

The mean age of the cases was 92.7±56.5 months, and 56% were female. Household contact history was present in 85% of the children, and the mean duration of contact was 137.2±114.1 days. Of the evaluated children, 78% were classified as uninfected contacts, 16% as TBI, and 6% as active TB disease. Tuberculin skin test positivity was detected in 19% of the cases. The mean age of children diagnosed with active TB was significantly lower than that of children with TBI and uninfected contacts (p=0.030). Thoracic computed tomography was performed in 24 cases with suspicious radiological findings, and findings compatible with TB were detected in 5 cases. Of the 6 children diagnosed with active TB, 5 had pulmonary TB and 1 had tuberculous lymphadenitis. Acid-fast bacilli (AFB) smear examinations performed in 14 cases requiring further investigation were all negative, whereas culture positivity was detected in half of the cases diagnosed with tuberculosis disease. Isoniazid prophylaxis was administered to all children diagnosed as contacts or TBI, and no active disease developed during the six-month follow-up period.

Conclusion

Household contact and younger age were identified as important risk factors for the development of active TB in children. Early and systematic screening of child contacts and timely initiation of isoniazid prophylaxis were found to be effective in preventing disease development. These findings support that early evaluation and preventive treatment of child contacts are fundamental strategies in the control of childhood tuberculosis.

Keywords:
Child, tuberculosis infection, tuberculosis contact, contact tracing

References

1
Burusie A, Enquesilassie F, Salazar-Austin N, Addissie A. Epidemiology of childhood tuberculosis and predictors of death among children on tuberculosis treatment in central Ethiopia: an extended Cox model challenged survival analysis. BMC Public Health. 2023; 23:1287.
2
Nurjana MA, Laksono AD, Wartana IK, Nursafingi A, Anastasia H, Tobing K, et al. Mycobacterium tuberculosis infection among children under fifteen years of age: A population-based study in Indonesia. Asian Pacific Journal of Tropical Medicine. 2023;16:506-14.
3
Thomas TA. Tuberculosis in children. Thorac Surg Clin. 2019;29:109-21.
4
Ding YE, Wong MTJ, Norazmi MN, Balakrishnan V, Tye GJ. Advancement in diagnostic approaches for latent tuberculosis: distinguishing recent from remote infections. One Health Outlook.2025;7:19.
5
Tüberküloz Tanı ve Tedavi Rehberi. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü, Yayın No:1387, 2026, Ankara.
6
Global tuberculosis report 2025. Geneva: World Health Organization; 2025. Licence: CC BY-NC-SA 3.0 IGO
7
Lee MS, Leung CC, Kam KM, Wong MY, Leung MC, Tam CM, et al. Early and late tuberculosis risks among close contacts in Hong Kong. Int J Tuberc Lung Dis.2008;12:281-7.
8
Ozsahin S, Arslan S, Çalışkan S, Doğan Ö, Berk S, Akkurt İ. Sivas Verem Savaş Dispanseri bölgesinde 1995–2004 yılları arasında kayıtlı tüberküloz hastalarının demografik özellikleri. Cumhuriyet Medical Journal. 2009;31:197-203.
9
Pekcan S, Tana Aslan A, Kiper N, Uysal G, Gürkan F, Patıroğlu T, et al. Multicentric analysis of childhood tuberculosis in Turkey. Turk J Pediatr. 2013;55:121-9.
10
Arısoy ES, Çiftçi E, Hacımustafaoğlu M, Kara A, Kuyucu N, Somer A, ve ark. Clinical practical recommendations for Turkish National Vaccination Schedule for previously healthy children (National Vaccination Schedule) and vaccines not included in the Schedule-2015. J Pediatr Inf 2015;9:12.
11
Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. International journal of epidemiology.1993;22:1154-8.
12
Martinez L, Cords O, Liu Q, Acuna-Villaorduna C, Bonnet M, Fox GJ, et al. Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis. Lancet Glob Health. 2022;10:e1307-6.
13
Ezeonu CT, Ikeagwulonu RC, Asiegbu UV, Obu DC, Briggs DC. Tuberculin skin tests following Bacille Calmette Guerin vaccination in Africa: a protocol for systematic review and meta-analysis. Pan Afr Med J. 2022; 41:12.
14
Chadha VK, Jaganath PS, Kumar P. Tuberculin sensitivity among children vaccinated with BCG under universal immunization programme. Indian J Pediatr. 2004;71:1063-8.
15
Mahomed N, Kilborn T, Smit EJ, Chu WCW, Young CYM, Koranteng N, et al. Tuberculosis revisted: classic imaging findings in childhood. Pediatr Radiol. 2023;53:1799-1828.
16
Kay AW, Madison M, Scandrett K, Ness T, Amuge P, Inbaraj LR, et al. Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children. Cochrane Database Syst Rev. 2022;9:CD013359.
17
Pourakbari B, Rostami Rad H, Sotoudeh M, Hosseinpour Sadeghi R, Mahmoudi S, Mamishi S. Pediatric pulmonary and extrapulmonary tuberculosis: immunological and diagnostic perspectives. BMC Infect Dis. 2026;26:485.
18
Kunkel A, Abel zur Wiesch P, Nathavitharana RR, Marx FM, Jenkins HE, Cohen T. Smear positivity in paediatric and adult tuberculosis: systematic review and meta-analysis. BMC Infect Dis. 2016;16:82.
19
Fu L, Liu K, Sun Y, Shu W, Ning Y, Liu Y, et al. Global, regional, and national burden of tuberculosis among children: a population-based study. Trop Med Infect Dis. 2026;11:43.
20
World Health Organization. Tuberculosis in children and adolescents. WHO Knowledge Sharing Platform 2023.
21
Kontturi A, Kekomäki S, Ruotsalainen E, Salo E. Tuberculosis contact investigation results among paediatric contacts in low-incidence settings in Finland. Eur J Pediatr. 2021;180:2185-92.
22
Boretsky A, Amanullah F, Hussain H, Malik AA, Brooks MB. Age and sex differences in paediatric tuberculosis care for child contacts. J Glob Health. 2026;16:04100.
23
Kilicaslan Z, Kiyan E, Kucuk C, Kumbetli S, Sarimurat N, Ozturk F, Yapici D, Al S, Erboran T, Iliksu N. Risk of active tuberculosis in adult household contacts of smear-positive pulmonary tuberculosis cases. Int J Tuberc Lung Dis. 2009;13:93-8.
24
Yigci D, Kayı İ, Demiroğlu YZ, Kutlu M, Kılıçaslan Z, Ergönül Ö. Tuberculosis in Turkiye: Epidemiological insights and recommendations for progress. Eur J Clin Microbiol Infect Dis. 2025;44:2323-30.
25
Ayieko J, Abuogi L, Simchowitz B, Bukusi EA, Smith AH, Reingold A. Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis. BMC Infect Dis. 2014;14:91.